Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

ATHN 9: Severe VWD Natural History Study

ClinicalTrials.gov ID: NCT03853486

Public ClinicalTrials.gov record NCT03853486. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 3:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.

Study identification

NCT ID
NCT03853486
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
108 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2019 (Actual)
Primary completion
Jun 12, 2026 (Actual)
Completion
Jun 26, 2026 (Actual)
Last update posted
Jul 13, 2026

2019 – 2026

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Center for Inherited Blood Disorders Orange California 92868 —
University of Colorado Denver Hemophilia and Thrombosis Center Aurora Colorado 80045 —
Connecticut Bleeding and Clotting Disorders Center Farmington Connecticut 06030 —
University of Florida Hemophilia Treatment Center Gainesville Florida 32610 —
Children's Healthcare of Atlanta/Emory Atlanta Georgia 30322 —
Bleeding and Clotting Disorders Institute Peoria Illinois 61615 —
Indiana Hemophilia and Thrombosis Center (IHTC) Indianapolis Indiana 46260 —
Louisiana Center for Bleeding and Clotting Disorders New Orleans Louisiana 70112 —
University of Michigan Hemophilia and Coagulation Disorders Ann Arbor Michigan 48109 —
Children's Hospital of Michigan Hemostasis and Thrombosis Center Detroit Michigan 48201 —
Michigan State University Center for Bleeding and Clotting Disorders East Lansing Michigan 48823 —
Mayo Comprehensive Hemophilia Center Rochester Minnesota 55905 —
Washington University Center for Treatment of Bleeding and Blood Clotting Disorders St Louis Missouri 63110 —
Nationwide Children's Hospital Columbus Columbus Ohio 43205 —
Oregon Health Portland Oregon 91239 —
Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Hemophilia Center of Western Pennsylvania Pittsburgh Pennsylvania 15213 —
Rhode Island Hemostasis & Thrombosis Center Providence Rhode Island 02903 —
University of Tennessee, University Clinical Health (Memphis) Memphis Tennessee 38119 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
Hemophilia Outreach Center Green Bay Wisconsin 54311 —
Versiti - Blood Center of Wisconsin Milwaukee Wisconsin 53201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03853486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2026 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03853486 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →